Deep Tech Startups

Octarine Bio is a synthetic biology platform company that engineers microorganisms to produce bio-based, low-impact ingredients and materials to replace unsustainable synthetic chemical processes across industries including pharmaceuticals, chemicals, food, and energy. Founded in 2018 based on research from Danish universities, the company applies precision fermentation and enzymatic enhancement to develop commercial-scale bio-manufacturing solutions.

1 investor

Ocutheia offers biotechnology consulting services with expert biotechnologists providing tailored solutions to clients.

1 investor

OD-OS manufactures the Navilas® 577s, a navigated retina laser system for ophthalmologic treatments including photocoagulation, microsecond pulsing therapy, and laser trabeculoplasty. The system serves retinal specialists and clinics performing precision laser treatments for conditions such as diabetic macular edema, central serous chorioretinopathy, and glaucoma.

1 investor

ODIN Materials develops composite construction materials made from agriculturally sourced feedstocks. The company is a materials startup focused on creating novel sustainable building materials.

1 investor

Odyssey builds orbital supercomputers designed to run AI training and inference workloads in space, using a space-native compute architecture intended to avoid the power, water, and buildout constraints of Earth-based data centers. Its offerings target AI labs, researchers, satellite operators, and scientific users needing large-scale compute for applications such as Earth-observation processing, climate, genomics, astronomy, and materials research.

1 investor

Odyssey develops space-based compute infrastructure, launching orbital supercomputers designed to deliver high-density, energy-efficient computing for AI workloads. The company builds a constellation of purpose-built space vehicles that operate as a distributed compute network, enabling large-scale AI training, inference, and specialized scientific workloads that cannot be accommodated by Earth-based infrastructure.

1 investor

OE Solutions manufactures optoelectronic transceiver solutions for broadband wireless and wireline networks, serving applications including wireless backhaul, MANs, LANs, SANs, and PONs. The company is headquartered in South Korea and supplies systems integrators globally.

1 investor

OI Analytical manufactures analytical instruments for laboratory use, enabling testing across environmental, food, fuel, and water sectors. The company adapts industry standard methods into its instruments to help customers generate accurate data for regulated testing.

1 investor

Okulo Aerospace provides UAV/drone-based aerial survey and inspection services across industries including solar parks, construction and infrastructure, oil and gas, mining, and environmental monitoring. Its offerings include thermal imaging, 3D modeling, and real-time data reporting for asset monitoring, safety compliance, and site surveying.

1 investor

Maker of explosion-proof industrial gas-detection hardware, including photoionization, electrochemical, catalytic, and infrared gas sensors, VOC detectors, audible/visual alarms, and a wearable safety watch with location and emergency calling. Devices communicate wirelessly and upload monitoring data to an IoT platform.

1 investor

Oligomerix is a biopharmaceutical company developing therapeutic compounds, with leadership focused on advancing drug candidates through clinical development stages.

1 investor

OliKrom develops color-intelligence materials with programmed color-change properties for industrial applications, including detection of overheating, impacts, hydrogen leaks, corrosion, wear indicators, anti-counterfeiting solutions, and adaptive coatings against solar heat. Founded in 2014, it serves large industrial companies in France and internationally with materials-science solutions supporting eco-innovation and smart-city development.

1 investor

Olive is a company focused on computing using light, geometry, and matter.

1 investor

Olive Capital is a seed-stage venture capital firm that invests in founders building in synthetic biology, software, and emerging platforms.

1 investor

OmniAb develops transgenic animal platforms engineered to generate human antibodies for therapeutic drug discovery, serving biopharmaceutical researchers and drug developers.

1 investor

OmniBio develops biologically-inspired AI models for autonomous robots and machines used in manufacturing, agriculture, and construction. The technology enables robots to learn and adapt in dynamic environments without traditional sensors or connectivity.

1 investor

OmniBuds develops ear-worn biosensing earbuds that continuously monitor cardiovascular and physiological signals through AI-powered analysis. The platform serves researchers, clinicians, and health-conscious individuals seeking accessible, unobtrusive insight into their body's cardiovascular responses during daily life.

1 investor

Omniose develops a platform for bioconjugate vaccine development using glycoconjugation technology to create vaccines against bacterial pathogens like Group B Streptococcus and Klebsiella pneumoniae. The company works with pharmaceutical and research partners to advance vaccine candidates through preclinical and clinical development.

1 investor

Omniref is a community-maintained code reference for programmers, offering questions, comments, links, and documentation tied to the code libraries developers already use. It is positioned as a developer tool for the programming community.

1 investor

Omnispace develops satellite-based connectivity that delivers next-generation mobile service, spectrum flexibility, and compute directly to mobile devices on Earth. Following a merger with Lynk, the company launched Elveo Mobile to provide this direct-to-device connectivity.

1 investor

OmniTier develops on-premise genomics analysis software and systems that use efficient memory-leveraged computing to enable faster and more cost-effective multiomic data analysis compared to cloud-based approaches.

1 investor

The company builds sovereign foundational AI models trained in Portuguese and run entirely in data centers located in Brazil, aimed at government use. It positions AI as a national asset so the state controls its own data, models, and the intelligence used for public decision-making.

1 investor

Order-made Medical Research Inc. (OMR) develops antibody drug discovery technologies, including its LIMAXYS platform for generating antibodies against multi-pass transmembrane targets, plus the INTAB and MUTAB platforms for internalizing and disease-specific mutation antibodies. The company aims to create new antibody-based therapies for hard-to-treat cancers, autoimmune diseases, and neurodegenerative disorders.

1 investor

OMX is a venture capital firm investing in life sciences and biotechnology companies across therapeutics, synthetic biology, and diagnostics. This page presents its portfolio companies rather than a product of its own.

1 investor